Children's Oncology Group's 2013 blueprint for research: Renal tumors

Clinically Relevant Subsets Identified by Gene Expression Patterns Support a Revised Ontogenic Model of Wilms Tumor: A Children's Oncology Group Study

(2015) Samantha Gadd et al.   NEOPLASIA

Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors

(2012) Andrew J. Wagner et al.   CANCER

Characteristics and outcome of stage II and III non-anaplastic Wilms’ tumour treated according to the SIOP trial and study 93-01

(2012) Norbert Graf et al.   EUROPEAN JOURNAL OF CANCER

The Management of Synchronous Bilateral Wilms Tumor

(2011) Thomas E. Hamilton et al.   ANNALS OF SURGERY

Sunitinib-induced Nephrotic Syndrome in Association with Drug Response in a Patient with Xp11.2 Translocation Renal Cell Carcinoma

(2011) Yao-Chung Liu et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Adaptive clinical trials in oncology

(2011) Donald A. Berry   Nature Reviews Clinical Oncology

Twenty-five year follow-up of childhood Wilms tumor: A report from the Childhood Cancer Survivor Study

(2011) Amanda M. Termuhlen et al.   PEDIATRIC BLOOD & CANCER

Evaluation of diagnostic performance of CT for detection of tumor thrombus in children with Wilms tumor: A report from the Children's Oncology Group

(2011) Geetika Khanna et al.   PEDIATRIC BLOOD & CANCER

Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network

(2010) G. G. Malouf et al.   ANNALS OF ONCOLOGY

Long-term Outcomes for Infants With Very Low Risk Wilms Tumor Treated With Surgery Alone in National Wilms Tumor Study-5

(2010) Robert C. Shamberger et al.   ANNALS OF SURGERY

Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma

(2010) Toni K. Choueiri et al.   CANCER

The role of SMARCB1/INI1 in the development of rhabdoid tumors

(2010) Charles Roberts et al.   CANCER BIOLOGY & THERAPY

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

(2010) Qianghua Hu et al.   JOURNAL OF CLINICAL INVESTIGATION

Pregnancy Outcome After Treatment for Wilms Tumor: A Report From the National Wilms Tumor Long-Term Follow-Up Study

(2010) Daniel M. Green et al.   JOURNAL OF CLINICAL ONCOLOGY

WT1 Mutation and 11P15 Loss of Heterozygosity Predict Relapse in Very Low-Risk Wilms Tumors Treated With Surgery Alone: A Children's Oncology Group Study

(2010) Elizabeth J. Perlman et al.   JOURNAL OF CLINICAL ONCOLOGY

Transcription Factor E3 and Transcription Factor EB Renal Cell Carcinomas: Clinical Features, Biological Behavior and Prognostic Factors

(2010) Gabriel G. Malouf et al.   JOURNAL OF UROLOGY

Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors

(2010) Katherine W. Eaton et al.   PEDIATRIC BLOOD & CANCER

Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: A report of the SIOP renal tumour study group

(2010) Marry M. van den Heuvel-Eibrink et al.   PEDIATRIC BLOOD & CANCER

Predicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression Analysis: A Report from the Renal Tumor Committee of the Children's Oncology Group

(2009) C.-C. Huang et al.   CLINICAL CANCER RESEARCH

Subsets of Very Low Risk Wilms Tumor Show Distinctive Gene Expression, Histologic, and Clinical Features

(2009) S. T. Sredni et al.   CLINICAL CANCER RESEARCH

Treatment of relapsed Wilms tumors: lessons learned

(2009) Filippo Spreafico et al.   Expert Review of Anticancer Therapy

Secondary malignant neoplasms after Wilms tumor: An international collaborative study

(2009) Norman E. Breslow et al.   INTERNATIONAL JOURNAL OF CANCER

Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program

(2009) Hernan Carol et al.   PEDIATRIC BLOOD & CANCER

Wilms tumor genetics: Mutations inWT1,WTX, andCTNNB1 account for only about one-third of tumors

(2008) E. Cristy Ruteshouser et al.   GENES CHROMOSOMES & CANCER

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group

(2007) Marcio Malogolowkin et al.   PEDIATRIC BLOOD & CANCER